You are here
MULTICELL TECHNOLOGIES, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Engineered human lgG1 for delivery of IDDM self-epitopes
Amount: $210,000.00DESCRIPTION (provided by applicant): Insulin-dependent diabetes mellitus is an autoimmune disease characterized by T cell attack of pancreatic islet cells leading to irreversible loss of the insulin ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
Recombinant IalphaIp: Treatment for Sepsis
Amount: $137,724.00DESCRIPTION (provided by applicant): Sepsis is the systematic and overwhelming response to infection. Once triggered, an uncontrolled cascade of coagulation, impaired fibrinolysis, and inflammation d ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Immortalized Pig Hepatocytes: A Drug Discovery Model
Amount: $139,314.00DESCRIPTION (provided by applicant): Drug-drug interactions can occur in a multiple drug regimen, where one drug interferes with the metabolism of another, leading to dangerous, unpredicted, and poten ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
MAMMALIAN HEPATOCYTES, A SOURCE OF THERAPEUTIC PROTEINS
Amount: $133,586.00DESCRIPTION (provided by applicant): The safe and efficient production of novel therapeutic proteins represents an expanding market of the biopharmaceutical industry that is fueled by the recent compl ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
N/A
Amount: $135,000.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $100,000.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health